Neurodegenerative conditions are a set of progressive and irreversible diseases that affect the structure and function of the brain, spinal cord, and nerves. These include Parkinson’s disease, Alzheimer’s disease, Huntington’s disease, and amyotrophic lateral sclerosis (ALS). Over time, these diseases can cause changes in motor and cognitive functions, leading to a disruption of the activities necessary for daily life. Neurodegenerative disorders are caused by the degeneration of neurons, which are the nerve cells responsible for transmitting signals to the brain and the rest of the body. This loss of neurons leads to a disruption in communication, causing difficulty in movement and cognition. It can result in problems with memory, comprehension, problem-solving, and reasoning. It can also lead to difficulty in controlling movement, balance, and coordination. Risk factors for neurodegenerative diseases include age, genetics, and a history of head trauma. Neurodegeneration can also be the result of certain medical conditions such as diabetes, hypertension, and cardiovascular diseases. In addition, certain lifestyle factors such as smoking, lack of exercise, unhealthy diet, or excessive consumption of alcohol can all increase the risk of developing these conditions. Currently, the treatments available for neurodegenerative diseases are limited and focus primarily on managing the symptoms. Medication can provide relief from some of the physical and cognitive impairments, but it does not stop the progression of the disease. There is ongoing research to identify treatments that can slow the progression of the disease, as well as improve the quality of life for those living with these conditions.
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : In silico in vitro and in vivo study of geraniol role in Alzheimer's disease
Bhuvanesh Baniya, Mohanlal Sukhadia University, India
Title : Prince transform: a wave-mechanical framework for real-time EEG analysis and early seizure prediction using chirp and drift detection
Mustafa A Khan, Sevaro Health Inc., United States
Title : Gut-brain axis in autism spectrum disorder: MicroRNAs as a critical mediator of pathogenesis
Rahem Rahmati, Shahrekord University of Medical Sciences, Iran (Islamic Republic of)